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ABSTRACT Virus resistance to antiviral therapies is an increasing concern that makes
the development of broad-spectrum antiviral drugs urgent. Targeting of the viral enve-
lope, a component shared by a large number of viruses, emerges as a promising strat-
egy to overcome this problem. Natural and synthetic porphyrins are good candidates for
antiviral development due to their relative hydrophobicity and pro-oxidant character. In
the present work, we characterized the antiviral activities of protoprophyrin IX (PPIX), Zn-
protoporphyrin IX (ZnPPIX), and mesoporphyrin IX (MPIX) against vesicular stomatitis vi-
rus (VSV) and evaluated the mechanisms involved in this activity. Treatment of VSV with
PPIX, ZnPPIX, and MPIX promoted dose-dependent virus inactivation, which was potenti-
ated by porphyrin photoactivation. All three porphyrins inserted into lipid vesicles and
disturbed the viral membrane organization. In addition, the porphyrins also affected viral
proteins, inducing VSV glycoprotein cross-linking, which was enhanced by porphyrin
photoactivation. Virus incubation with sodium azide and -tocopherol partially protected
VSV from inactivation by porphyrins, suggesting that singlet oxygen (1O2) was the main
reactive oxygen species produced by photoactivation of these molecules. Furthermore,
1O2 was detected by 9,10-dimethylanthracene oxidation in photoactivated porphyrin
samples, reinforcing this hypothesis. These results reveal the potential therapeutic appli-
cation of PPIX, ZnPPIX, and MPIX as good models for broad antiviral drug design.
KEYWORDS photoactivation, porphyrin, singlet oxygen, vesicular stomatitis virus,
viral inactivation
Despite the increasing number of antiviral drugs available nowadays, therapeuticsfor viral diseases often fail due to drug resistance development by the target
viruses. In the search for antiviral agents with a broad spectrum of activity against
viruses, antiviral agents targeting the viral envelope, a component shared by a large
number of viruses, emerge as promising compounds able to overcome the drug
resistance problem. Porphyrins, amphipathic molecules able to interact with mem-
branes, appear to be good candidates for the development of such antivirals. Porphy-
rins are formed by four pyrrole rings linked by methine bonds. The nitrogen atoms in
the center of the ring form a pocket able to coordinate metallic ions, conferring to
porphyrin the ability to absorb light at additional wavelengths and act in catalytic
transformations (1). These activities allow porphyrins to be involved in important
biological processes, such as respiration (heme) and photosynthesis (chlorophyll and
bacteriochlorophyll) (2).
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Many viruses of different families have been inactivated by porphyrins or porphyrin
derivatives, including enveloped viruses, such as HIV-1 (3, 4), poxvirus (5), hepatitis B
virus (6, 7), hepatitis C virus (7, 8), Marburg, Tacaribe, and Junin viruses (7), bovine
herpesvirus (9), and dengue and yellow fever viruses (7, 10), as well as nonenveloped
viruses, such as poliovirus (9). Porphyrins and their derivatives were also used as
enhancers of the effects of other antiviral drugs, as was observed for the combination
of heme (or its analogues) with zidovudine for the treatment of HIV-1 infection (11, 12),
and some porphyrins were conjugated with the neuraminidase inhibitor zanamivir for
the treatment of influenza virus infections (13).
The mechanism by which porphyrins act as antivirals is related to their hydrophobic
and pro-oxidant characteristics. Due to their relative hydrophobicity, porphyrins are
able to interact with biological membranes (14), so enveloped viruses are potential
candidates for targeting by porphyrin and subsequent inactivation through viral en-
velope destabilization and oxidation. These molecules also induce the generation of
reactive oxygen species (ROS), promoting lipid, protein, and nucleic acid oxidation
(15–19). The properties of porphyrins vary according to their structure and the metal
ion present in the center of the tetrapyrrole, as well as substituents attached to the
pyrrolic rings or to the methine bridges (1). Additionally, porphyrins are colored
compounds that undergo photoactivation, being widely used in photodynamic therapy
(PDT), a method used for microorganism inactivation (2, 20, 21). Hepatitis A virus and
HIV are examples of viruses efficiently inactivated by the use of porphyrins as photo-
sensitizers in PDT (22, 23). Also, several enveloped viruses belonging to different
families were strongly inactivated by phthalocyanines, molecules closely related to
porphyrins (10, 24–28). The ability of porphyrins to act as photosensitizers is related to
their property of catalyzing ROS generation. ROS generation by photosensitizers occurs
through two different pathways that may occur separately or simultaneously (2, 20, 29).
In the type I pathway, the superoxide anion or hydroxyl radical is generated through
electron transfer from the excited photosensitizer, while the type II pathway involves
singlet oxygen (1O2) generation by energy transfer from the photoactivated molecule
(2, 20, 29).
In this work, we evaluated the antiviral activities and the mechanisms of action of
three porphyrins, protoporphyrin IX (PPIX), zinc protoporphyrin IX (ZnPPIX), and meso-
porphyrin IX (MPIX) (Fig. 1A, E, and I, respectively), using as a model an enveloped virus,
vesicular stomatitis virus (VSV). VSV is a member of the Rhabdoviridae family and causes
an acute disease that mainly affects cattle, pigs, and horses (30). The disease is
characterized by the development of vesicles and ulcers in the oral cavity and, less
frequently, in the teats and coronary bands, leading to decreases in milk and meat
production. The VSV structure is composed of a nucleocapsid surrounded by the
viral envelope. The envelope is a lipid bilayer derived from the host cell and
contains trimers of a single type of an integral glycoprotein, named the G protein,
which mediates virus entry into the target cell through endocytosis and catalyzes
the fusion of viral and endosomal membranes, an essential step of infection (31).
The nucleocapsid consists of the viral RNA genome tightly associated with the
nucleoprotein (N). VSV RNA is a negative-sense, single-stranded molecule that
depends on viral RNA-dependent RNA polymerase, a complex formed by the L
protein and the phosphoprotein (P), to replicate (32). The virion also contains the
matrix (M) protein, located between the envelope inner surface and nucleocapsid
(33). We demonstrate that PPIX, ZnPPIX, and MPIX inactivate VSV and that their
antiviral activities are strongly enhanced by porphyrin photoactivation. We found
that, besides the interaction of the porphyrins with the viral envelope, which is
destabilized, these molecules promote viral protein cross-linking and degradation.
The use of antioxidants and spectroscopic analyses revealed that 1O2 is the main
reactive species produced by the photoactivated porphyrin, with the type II path-
way being the mechanism of porphyrin-induced VSV inactivation.
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RESULTS
Treatment with PPIX, ZnPPIX, and MPIX inactivates VSV. VSV was incubated with
different concentrations of PPIX, ZnPPIX, and MPIX for 1 h either in the dark or under
light to promote their photoactivation, and virus infectivity was evaluated by plaque
assay (Fig. 1). All porphyrins tested presented anti-VSV activity even without photoac-
tivation, with the reduction in viral titer being about 10-fold for ZnPPIX and 1,000-fold
for PPIX and MPIX when they were each used at a 1 M concentration. At 5 M, all
porphyrins tested were able to completely abolish VSV infectivity (Fig. 1B, F, and J). To
precisely compare the antiviral activity of each porphyrin, the half-maximal (50%)
inhibitory concentrations (IC50s) were calculated (Table 1).
Photoactivation of the porphyrins significantly enhanced their antiviral activities,
with 0.1 M ZnPPIX, 0.01 M PPIX, and 0.1 M MPIX completely abolishing VSV
infectivity (Fig. 1C, G, and K, respectively). The IC50s of the photoactivated porphyrins
against VSV were also calculated (Table 1). Photoactivated ZnPPIX and PPIX showed
IC50s against VSV 100-fold lower than those observed with nonphotoactivated ZnPPIX
and PPIX, while the IC50 of photoactivated MPIX was decreased about 50-fold relative
FIG 1 PPIX (A to D), ZnPPIX (E to H), and MPIX (I to L) inactivate VSV. The molecular structures of PPIX (A), ZnPPIX (E), and MPIX (I) are shown. VSV was incubated
with the indicated concentrations of the porphyrins for 1 h in the dark (B, F, and J) or under illumination using a 30-W fluorescent lamp with a luminous
emittance of 2,000 lx positioned 10 cm from the sample (C, G, and K), and the virus infectivity of BHK-21 cells was assessed by plaque assay. The kinetics of
VSV inactivation under photoactivating conditions was evaluated for PPIX at 0.001 M (●) and 0.01 M () concentrations (D), for ZnPPIX at 0.01 M (●) and
0.1 M () concentrations (H), and for MPIX at 0.01 M (●) and 0.1 M () concentrations (L). As controls, the titers of VSV samples incubated with 5% DMSO
under the same conditions were measured (}). Data are represented as means  SEMs for at least three independent samples. P values (for porphyrin-treated
versus nontreated samples) are shown on the top each bar. n.d., not determined.
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to that of nonphotoactivated MPIX. We also characterized the kinetics of porphyrin-
induced VSV inactivation under photoactivating conditions, using 0.001 M and 0.01
M PPIX (Fig. 1D), 0.01 M and 0.1 M ZnPPIX (Fig. 1H), or 0.01 M and 0.1 M MPIX
(Fig. 1L). Altogether, these data suggest that all porphyrins tested have anti-VSV
activity, which is enhanced by photoactivation.
PPIX, ZnPPIX, and MPIX interact with VSV envelope. Porphyrins are amphipathic
molecules that interact with biological membranes (19). PPIX, ZnPPIX, and MPIX are
fluorescent porphyrins, and their fluorescence emission increases as the polarity of the
medium decreases (Fig. 2A to C). Using this property, it was possible to calculate their
partition coefficients (Kps) for membranes of different lipid compositions. For this, we
recorded the PPIX, ZnPPIX, and MPIX fluorescence emission spectra after progressive
TABLE 1 Porphyrin IC50s against VSV
Porphyrin
Mean IC50  SEM (nM)
Nonphotoactivated Photoactivated
PPIX 8.294 1.013 0.09764 0.002566
ZnPPIX 101.5 34.18 1.028 0.5577
MPIX 47.18 26.21 0.9659 0.5499
FIG 2 PPIX, ZnPPIX, and MPIX interact with lipid membranes and interfere with VSV membrane ordering. (A to C) Fluorescence emission spectra of PPIX (A),
ZnPPIX (B), and MPIX (C) in PBS (light gray curves) and in ethanol (dark gray curves). Excitation wavelengths were 394, 407, and 394 nm for PPIX, ZnPPIX, and
MPIX, respectively. a.u., arbitrary units. (D to F) Partition curves of PPIX (D), ZnPPIX (E), and MPIX (F) to PC (100%), PC-PE (4:1), PC-PS (4:1), PC-Chol (2:1), PC-Sph
(2:1), or PC-Sph-Chol (1:1:1) vesicles obtained by progressive LUV addition to a solution of 2.8 M for ZnPPIX and PPIX and 2.6 M for MPIX. I, fluorescence
intensity in the presence of LUVs; I0, fluorescence intensity in the absence of LUVs. (G to I) Laurdan GP values after progressive addition of PPIX (G), ZnPPIX
(H), and MPIX (I) to a solution containing laurdan-labeled VSV. GP values were calculated as described in Materials and Methods using the emission peaks at
440 and 490 nm. All data correspond to means  SEMs from at least three independent experiments.
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addition of large unilamellar vehicles (LUVs) composed of 1-palmitoyl-2-oleyl-sn-glycero-3-
phosphatidylcholine (POPC)–1-palmitoyl-2-oleyl-sn-glycero-3-phosphatidylethanolamine
(POPE) (4:1), POPC–1-palmitoyl-2-oleyl-sn-glycero-3-phosphatidylserine (POPS) (4:1), POPC-
cholesterol (Chol) (2:1), POPC-sphingomyelin (Sph) (2:1), and POPC-Sph-Chol (1:1:1) and
plotted the spectral area as a function of the lipid concentration (Fig. 2D to F). All porphyrins
tested were able to interact with LUVs with high Kp values (Table 2). No significant
difference in the compositions of the different LUVs was detected, but MPIX and PPIX
presented higher Kp values than ZnPPIX for all LUVs tested.
Although the porphyrins’ partition to LUVs is a good tool for studying the porphyrin-
membrane interaction, viral envelopes contain proteins at a high density, and these
proteins may interfere with membrane disturbance by porphyrins. Thus, to evaluate the
porphyrin-membrane interaction in the virus context, we used laurdan generalized
polarization (GP) to assess the porphyrin-induced changes in viral envelope ordering.
PPIX, ZnPPIX, and MPIX were progressively added to a solution containing VSV that had
previously been labeled with laurdan, and laurdan spectral shifts were used for GP
calculation. All porphyrins tested induced a laurdan GP decrease, indicating changes in
the membrane ordering of the VSV envelope (Fig. 2G to I). Interestingly, photoactivated
porphyrins promoted the same GP changes as those induced by nonphotoactivated
porphyrins (data not shown), suggesting that porphyrin partition to the VSV envelope
is not dependent on its photoactivation. This result also supports the suggestion that
the laurdan spectral shifts observed in labeled VSV are due to changes in viral
membrane ordering and are not yet due to the total envelope disruption promoted by
the ROS generated during the porphyrin photoactivation process.
PPIX, ZnPPIX, and MPIX promote VSV G glycoprotein cross-linking. To evaluate
whether PPIX, ZnPPIX, and MPIX had any effect on VSV proteins, protein damage in VSV
incubated with photoactivated and nonphotoactivated porphyrins was evaluated by
SDS-PAGE. The VSV protein profile in 10% SDS-polyacrylamide gels allowed the obser-
vation of 4 of the 5 viral structural proteins: the L protein (241 kDa), G glycoprotein (55
kDa), N nucleoprotein (47 kDa), and M (matrix) protein (26 kDa) (Fig. 3). Interestingly, a
band of approximately 130 kDa was observed for ZnPPIX-, PPIX-, and MPIX-treated VSV
samples. For the virus treated under nonphotoactivating conditions, this band became
evident at a porphyrin concentration of 5 M, while for photoactivated porphyrin-
treated VSV samples, it appeared after treatment with lower porphyrin concentrations
(Fig. 3). This band could correspond either to cross-linked viral proteins or to an L
protein degradation product. To discriminate these possibilities, the 130-kDa band was
extracted from the gel and submitted to mass spectrometry (MS) analyses. The results
showed the presence of G glycoprotein, suggesting that the band corresponds to large
complexes of G glycoproteins (data not shown). Additionally, for photoactivated sam-
ples, the G glycoprotein band seemed to be significantly reduced in VSV treated with
MPIX at a 1 M concentration. The M protein band was also reduced in VSV samples
under this condition. Taken together, these results suggest that PPIX, ZnPPIX, and MPIX
induce VSV G glycoprotein cross-linking, which is enhanced by porphyrin photoacti-
vation. In this context, the loss of infectivity of porphyrin-treated VSV may be explained
by G glycoprotein cross-linking in the virus envelope.
PPIX, ZnPPIX, and MPIX photoactivation induces 1O2 generation. The enhanced
loss of infectivity and the enhanced G glycoprotein cross-linking in photoactivated
TABLE 2Membrane Kp for PPIX, ZnPPIX, and MPIX
Lipid mixture
Mean Kp  SEM (103)
PPIX ZnPPIX MPIX
POPC-POPS (4:1) 8.30 0.99 1.63 0.19 21.47 1.41
POPC-POPE (4:1) 14.10 0.99 2.91 0.31 25.99 4.35
POPC-Chol (2:1) 10.91 2.854 3.62 0.22 14.95 2.13
POPC-Sph (2:1) 11.60 0.76 2.99 0.50 21.73 0.09
POPC-Sph-Chol (1:1:1) 12.83 2.19 1.75 0.41 19.08 0.71
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porphyrin-treated VSV suggest that ROS generation may be implicated in porphyrin
antiviral activity. To test which reactive oxygen species is generated by PPIX, ZnPPIX,
and MPIX photoactivation, porphyrin-treated VSV samples were incubated with differ-
ent antioxidants and VSV infectivity was measured. Treatment with reduced glutathi-
one, a free radical scavenger with a type I mechanism, did not alter photoactivated
porphyrin-induced VSV inactivation at all concentrations tested (Fig. 4A to C). On the
other hand, the loss of infectivity observed for PPIX-, ZnPPIX-, or MPIX-treated VSV
under photoactivating conditions was partially reversed by treatment with sodium
azide (Fig. 4D to F) and -tocopherol (Fig. 4G to I), water- and lipid-soluble 1O2
quenchers (type II mechanism), respectively. These results suggest that 1O2 may be the
primary ROS produced by photoactivation of these porphyrins when they are in contact
with the VSV envelope. Interestingly, -tocopherol, a lipid-soluble 1O2 quencher, was
more effective in protecting MIPX-treated VSV (Fig. 4I).
Altogether, these results suggest that 1O2 generation in the VSV envelope by
photoactivated porphyrins promotes G glycoprotein cross-linking and, consequently,
viral inactivation. To obtain further evidence to confirm this hypothesis, we evaluated
the ability of photoactivated PPIX, ZnPPIX, and MPIX to generate 1O2, using for this
9,10-dimethylanthracene (DMA), a 1O2-specific trap. Although DMA oxidation by 1O2
can be observed by fluorescence quenching, the absorbance of the porphyrins near the
DMA excitation wavelength impaired its use here in fluorescence experiments for 1O2
detection. For this reason, DMA conversion by porphyrin-originated 1O2 was evaluated
FIG 3 VSV treatment with PPIX, ZnPPIX, and MPIX promotes G glycoprotein cross-linking. VSV was incubated with the indicated concentrations of PPIX, ZnPPIX,
and MPIX for 1 h in the dark (A to C) or under illumination, provided using a 30-W fluorescent lamp with a luminous emittance of 2,000 lx positioned 10 cm
from the sample (D to F), and the VSV protein profile was assessed by 10% SDS-PAGE. Arrows, the band corresponding to G protein cross-linking. Images are
representative of those from three independent experiments.
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by 1H nuclear magnetic resonance (NMR), taking advantage of the fact that the DMA
and oxidized DMA (oxi-DMA) methyl peaks could be easily identified at 3.1 ppm and 2.1
ppm, respectively (Fig. 5A). The time-dependent 1O2 generation by photoactivated
porphyrins is shown in Fig. 5B to D. After 30 min of incubation with 0.001 M PPIX, 0.1
M ZnPPIX, or 0.01 M MPIX, all DMA was converted to oxi-DMA. This result confirms
FIG 4 1O2 quenchers protect VSV from photoactivated PPIX, ZnPPIX, and MPIX antiviral activity. VSV particles were treated with 0.01 M PPIX (A, D, and G),
0.1 M ZnPPIX (B, E, and H), or 0.1 M MPIX (C, F, and I) and simultaneously incubated with glutathione (GSH) (A to C), sodium azide (D to F), and -tocopherol
(-toco) (G to I) at the indicated concentrations for 5 min under photoactivating conditions. Virus infectivity was assessed by plaque assay in BHK-21 cells. Data
are represented as means  SEM for at least three independent samples. P values are indicated.
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that 1O2 is the main ROS produced by photoactivation of PPIX, ZnPPIX, and MPIX (type
II mechanism) and is probably responsible for viral protein damage.
Porphyrins inactivate VSV during cell infection without a loss of cellular
viability. To evaluate the potential application of porphyrin-induced viral inactivation
to disease treatment or blood disinfection, we performed a set of experiments in which
the infection assay was carried out with the virus and the porphyrins added to the cell
culture at the same time (Fig. 6A). We found that even using this alternative experi-
mental design, VSV inactivation could be observed, although to a lesser extent than when
the purified virus was previously incubated with the porphyrins. It is important to highlight
that even at concentrations that induced viral titer decrease, cell viability was preserved
(Fig. 6B), reinforcing the potential clinical use of PPIX, ZnPPIX, and MPIX as antivirals.
DISCUSSION
Viral envelopes are promising targets for broad-spectrum antiviral agents, since the
membranes of all enveloped viruses are relatively similar, as they derive from the host
cell membrane. Envelope-targeted antivirals would act by affecting lipid bilayer fluidity,
impairing the fusion between viral and cellular membranes, an essential event for a
successful viral infection (34, 35). In this context, porphyrins appear to be good
candidates for broad-spectrum antiviral agents, as they can induce membrane disorder
and permeability, even independently of photoactivation-induced ROS generation (19).
FIG 5 1O2 formation by photoactivation of porphyrins. (A) DMA/oxi-DMA conversion was evaluated by 1H NMR, comparing the DMA methyl peaks at 3.1 ppm
and 2.1 ppm, respectively. PPIX (B), ZnPPIX (C), and MPIX (D) at final concentrations of 0.001 M, 0.1 M, and 0.01 M, respectively, were added to a solution
of 20 M DMA in chloroform and exposed to visible light (provided by a 30-W lamp with luminous emittance of 2,000 lx at a distance of 10 cm) (}). As controls,
the spectra of nonphotoactivated samples () were recorded after 60 min of incubation in the dark. The data represent the means of two independent
measurements. rel, relative peak intensity.
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In this work, we analyzed the inactivation of the enveloped virus VSV by three
porphyrins, PPIX, MPIX, and ZnPPIX. In addition to its economic and veterinary impor-
tance, VSV is a good model for viral inactivation studies since it is a fast-growing and
easily titrated virus. Incubation of VSV with the three porphyrins tested decreased its
infectivity in a concentration-dependent manner. The antiviral action of PPIX, MPIX,
and ZnPPIX without photoactivation may be attributed to their ability to intercalate
membranes, as demonstrated by studies of their partition into LUVs. MPIX and PPIX
presented higher p values than ZnPPIX, as expected because of their high hydropho-
bicities. Accordingly, the interaction between porphyrins and membranes seems to be
dependent only on hydrophobicity, since no significant difference in the porphyrin-LUV
interaction was observed for vesicles of different lipid compositions. In addition, all
three porphyrins interfered with viral membrane ordering, leading to a decrease in
laurdan GP values, although no membrane phase transition was observed. These results
confirm the porphyrin interaction with the VSV envelope and may be correlated with
VSV inactivation. Furthermore, PPIX and MPIX, which show a higher affinity to mem-
branes than ZnPPIX, were slightly more effective than ZnPPIX in inactivating VSV,
corroborating the hypothesis that virus inactivation depends on porphyrin insertion
into the viral envelope.
FIG 6 VSV is inactivated by PPIX, ZnPPIX, and MPIX treatment during cell infection. (A) Viral inactivation
by porphyrins was performed during cell infection with VSV. BHK-21 cells were infected with an MOI of
1, concomitantly with treatment with porphyrins at the indicated concentrations, for 1 hour, under
illumination using a 30-W fluorescent lamp of luminous emittance of 2,000 lx, positioned 10 cm from the
sample. After 6 h, culture media were collected and frozen. Virus titers were quantified by plaque assay
in BHK-21 cells. (B) Porphyrin cytotoxicity was assessed in BHK-21 cells. Cells were incubated with
different concentrations of PPIX, ZnPPIX, and MPIX in culture medium without FBS for 1 hour, under
illumination using a 30-W fluorescent lamp of luminous emittance of 2,000 lx, positioned 10 cm from the
sample. Then, cell viability was evaluated using the MUSE count and viability kit (Millipore). Data are
represented as means  SEM from at least three independent samples. P values are indicated in the
figure.
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Porphyrins not only are hydrophobic molecules, but they also show a photoactive
character, two features that make them attractive for PDT against enveloped viruses.
Indeed, the majority of the photosensitizers used in PDT against microorganisms are
based on the backbone of tetrapyrroles (2, 20). Accordingly, here we showed that the
antiviral activity of PPIX, MPIX, and ZnPPIX against VSV was significantly potentiated by
photoactivation, suggesting that inactivation efficiency would depend on the genera-
tion of deleterious ROS by porphyrin photoactivation close to envelope lipids and
proteins, irreversibly reacting with them. In agreement with this idea, our results
demonstrated that MPIX, followed by PPIX, had a greater affinity for membrane lipids
as MPIX and PPIX presented higher Kp values in the partition experiments, together
with higher antiviral activity, than ZnPPIX. Surprisingly, the antiviral activity of photo-
activated ZnPPIX was comparable to that of photoactivated MPIX, suggesting that the
antiviral activity of ZnPPIX may reside more in its ability to generate ROS when it is
photoactivated than in its hydrophobic character.
The appearance of a G protein-containing band of approximately 130 kDa in the
electrophoretic analysis of viral proteins after treatment with porphyrins, together with
a decrease in the intensity of the typical G protein band, suggests that G protein
cross-linking occurs in porphyrin-treated VSV. Although cross-linking was also observed
in nonphotoactivated porphyrin-treated VSV (when porphyrin was used at higher
concentrations), these results imply that ROS generation by photoactivated porphyrins
promotes G protein damage, which is involved in virus inactivation. In this regard, the
relatively high rate constants for the 1O2 reaction with some protein side chains make
the proteins the main target for photodynamic agents (36, 37), and both cross-linking
between proteins and protein degradation can be a result of the oxidation mediated by
the photosensitizer (37, 38). The G protein damage induced by photoactivated MPIX
was more evident than that caused by ZnPPIX. In addition, a decrease in the M protein
band intensity was also observed for VSV samples treated with photoactivated MPIX,
corroborating the hypothesis that this porphyrin inserts deeper into the VSV envelope
than the others. Porphyrin derivatives and phthalocyanines were also shown to have
photodynamic antiviral activity against VSV (24, 25, 39–42), but although protein
cross-linking was reported in one of these studies (39), the mechanisms by which
protein damage was caused by the photoactivated molecule was not well documented.
We used three different antioxidants to determine which ROS generation pathway
was involved in PPIX, ZnPPIX, and MPIX antiviral activity. We found that sodium azide
and -tocopherol partially protected VSV from inactivation by the porphyrins, showing
that 1O2 is the deleterious species involved in the antiviral activity of the photoacti-
vated porphyrins. The detection of the oxi-DMA methyl peak in the NMR spectrum of
photoactivated porphyrin reinforced this hypothesis. Interestingly, -tocopherol was
more effective than sodium azide in protecting VSV from the antiviral activity of MPIX.
These results agree with the hypothesis that MPIX, being more hydrophobic, would act
deeper in the virus envelope, so that a hydrophobic 1O2 quencher, like -tocopherol,
would be more effective than a soluble one, like sodium azide.
For a long time, PDT research was mostly targeted to cancer therapy, leading to the
approval of manifold PDT protocols for the treatment of malignant and nonmalignant
conditions (20, 43), with many porphyrin-related molecules being submitted to clinical
trials and clinical approval being obtained for some of them (20). For instance, the PPIX
precursor, 5-aminolevulinic acid (ALA), has been successfully used in the topical treat-
ment of skin cancer and other dermatologic lesions (20, 44, 45). On the other hand,
although PDT was first proposed as a means to kill microorganisms, only with the
emergence of multidrug-resistant microorganisms has the use of PDT against microbes
been revisited (20, 46). Since then, several attempts to discover photosensitizing drugs
suitable for antimicrobial and antiviral therapies have been made. As examples, viral
lesions were cleared both by ALA-PDT treatment of herpes simplex virus-infected
animals and through light irradiation of cell-accumulated PPIX in an HIV-infected
patient (47). Here we provide preliminary data demonstrating that noncytotoxic doses
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of porphyrins present antiviral activity directly on cultured cells. In this context, topical
antiviral treatment with these porphyrins should be further investigated.
Finally, regardless of the significant reduction of pathogen transmission by blood
and derivatives through pathogen screening and donor counseling, the risk, involving
the window period of contamination, still persists (48, 49). In order to minimize this risk,
the development of new approaches of blood disinfection with drugs targeting a broad
range of pathogens should be addressed. The use of porphyrins and its analogs in PDT
for viral inactivation of blood products has proved successful (24, 25, 28, 50, 51), and
VSV is often used as a model virus in such tests (24, 25, 41). In this context, PPIX, ZnPPIX,
and MPIX could be used for blood disinfection as well and should be tested for their
cytotoxicity for blood cells.
In conclusion, although the findings of other studies on the use of porphyrins in PDT
against several viruses are available, in this work we not only show by different and
complementary techniques that PPIX, ZnPPIX, and MPIX have antiviral activity against
VSV but also describe the mechanism involved in these processes, which includes
porphyrin intercalation into the virus envelope lipid bilayer with changes in lipid
ordering and 1O2 production after their photoactivation.
MATERIALS AND METHODS
Materials and sample preparation. PPIX, ZnPPIX, and MPIX were purchased from Frontier Scientific.
All porphyrins were diluted in dimethyl sulfoxide (DMSO) to a stock concentration of 50 mM and frozen
at 20°C. All solutions were prepared in the dark. For the experimental procedures, porphyrins were
diluted in culture medium, with the final DMSO concentration being maintained at 5%, which did not
affect VSV infectivity (data not shown). 1-Palmitoyl-2-oleyl-sn-glycero-3-phosphatidylcholine (POPC),
1-palmitoyl-2-oleyl-sn-glycero-3-phosphatidylserine (POPS), 1-palmitoyl-2-oleyl-sn-glycero-3-phosphati-
dylethanolamine (POPE), sphingomyelin (egg), and cholesterol were purchased from Avanti Polar Lipids.
Large unilamellar vesicles (LUVs) with an average diameter of 100 nm were prepared by extrusion
methods as described previously (52, 53). 2-Dimethylamino-6-lauroylnaphthalene (laurdan) and 9,10-
dimethylanthracene (DMA) were obtained from Sigma-Aldrich. -Tocopherol and glutathione (GSH) were
purchased from Sigma-Aldrich. Sodium azide was acquired from USB Corporation. GSH and sodium azide
stock solutions (250 mM and 1 M, respectively) were prepared in Milli-Q water, while the 200 mM
-tocopherol stock solution was prepared in ethanol. For virus incubation, -tocopherol was first diluted
to 50 mM in ethanol and then diluted in culture medium to 1 mM and 500 M (2% and 1% ethanol,
respectively). The final ethanol concentrations used did not alter the VSV titer (data not shown).
Cell culture. BHK-21 cells were cultured in alpha minimum essential medium (-MEM; Gibco, Life
Technologies Inc.) supplemented with 10% fetal bovine serum (FBS; LGC Biotecnologia) at 37°C in a 5%
CO2 atmosphere.
Virus propagation and purification. The VSV Indiana strain was propagated in BHK-21 cells. Cells
were infected at a multiplicity of infection (MOI) of 0.1, and after 16 to 20 h, the conditioned medium
containing the virus particles was harvested and centrifuged at 2,000  g for 30 min to remove the cell
debris. The supernatant was centrifuged at 36,000 rpm for 2 h 30 min at 4°C using a Beckman Ti45 rotor.
Afterward the supernatant was discarded and the pellet containing the VSV particles was incubated with
3E buffer (120 mM Tris, 60 mM sodium acetate, 3 mM EDTA, pH 7.4) at 4°C overnight. Then, the pellet
was resuspended and deposited in a discontinuous gradient of 15% and 60% (wt/vol) sucrose in 3E
buffer and centrifuged at 36,000 rpm for 1 h at 4°C using a Beckman SW-41 rotor. The visible virus band
was collected, and the buffer was changed to phosphate-buffered saline (PBS; pH 7.4) using an Amicon
3K system (Merck, Millipore Ltd.). Purification was confirmed by SDS-PAGE. The virus titer and protein
concentration were determined by plaque assay in BHK-21 cells and the Lowry method, respectively.
Purified virions were stored at 70°C.
Virus titration by plaque assay. The virus titer was quantified by plaque assay in BHK-21 cells. Virus
samples were serially diluted in -MEM, and after 1 h of infection, 1% carboxymethyl cellulose in -MEM
with 2% (vol/vol) FBS was added to the wells. Cells were kept in culture at 37°C in a 5% CO2 atmosphere
for 16 h. The cells were then fixed with 4% formaldehyde solution and stained with crystal violet (1%
[wt/vol] crystal violet powder in 20% methanol) for plaque visualization.
Porphyrin treatment for VSV inactivation. Purified VSV particles were incubated for 1 h in the dark
with different concentrations of PPIX, ZnPPIX, and MPIX in culture medium without FBS. For determi-
nation of the antiviral activity of the photoactivated porphyrins, treated VSV particles were illuminated
using a 30-W fluorescent lamp with a luminous emittance of 2,000 lx positioned 10 cm from the sample.
The half-maximal (50%) inhibitory concentration (IC50) was determined by nonlinear regression with a
sigmoidal and variable slope profile using GraphPad Prism (version 6.0) software. To evaluate the antiviral
activities of the porphyrins when they were added directly to the cell culture, VSV infection was carried
out with nonpurified virus at an MOI of 1, different concentrations of PPIX, ZnPPIX, and MPIX were
immediately added to culture medium without FBS, and the culture was incubated at room temperature
for 1 h under illumination as described above. After 1 h of infection, the culture medium was replaced
with medium supplemented with 10% FBS. At 6 h postinfection (hpi), conditioned medium was collected
and the virus titer was determined by plaque assay.
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Cell viability assays. BHK-21 cells were incubated for 1 h under illumination as described above with
different concentrations of PPIX, ZnPPIX, and MPIX in culture medium without FBS. Then, cell viability
was evaluated using a Muse count and viability kit (Millipore) as described by the manufacturer.
Antioxidant treatment. Prior to VSV treatment with porphyrins, GSH, sodium azide, or -tocopherol
was added to the viral samples, followed immediately by incubation with the porphyrins for 5 min under
illumination with a 30-W fluorescent lamp with a luminous emittance of 2,000 lx positioned 10 cm from
the sample. After incubation, the virus suspensions were diluted at least 10-fold in culture medium for
titration.
Analysis of viral proteins after porphyrin treatment. Proteins from control or porphyrin-treated
VSV were analyzed by 10% SDS-PAGE followed by Coomassie blue G staining. The modified viral proteins
were identified by nano-liquid chromatography (LC)- tandem mass spectrometry (MS/MS) after in-gel
digestion (data not shown). The sections of interest were manually excised and submitted to trypsin
digestion. To remove the stain, the sections were washed by incubation overnight with 25 mM NH4HCO3
in 50% acetonitrile at room temperature. The reduction of protein disulfide bonds was performed by the
addition of 10 mM dithiothreitol (USB Corporation) in 25 mM NH4HCO3 at 56°C for 1 h, followed by a
washing step with 25 mM NH4HCO3. The alkylation of the free SH groups was performed in the dark by
the addition of 55 mM iodoacetamide in 25 mM NH4HCO3 (USB Corporation) for 45 min at room
temperature. Gel slices were dehydrated with 100% acetonitrile and rehydrated in 10 l of trypsin
(modified sequencing grade; Promega) solution (0.01 g l1 in 25 mM NH4HCO3). The digestion step
occurred overnight at 37°C, and the peptides generated were extracted from the gel pieces after 2 steps
of sonication for 15 min with 5% trifluoroacetic acid (TFA) dissolved in 50% acetonitrile. This solution was
transferred to a clean 500-l microtube and concentrated in a Speed-Vac system. Each sample was then
solubilized in 20 l 0.1% formic acid and 3% acetonitrile in deionized water. The extracted peptides were
loaded in a nanoAcquity system (Waters) and desalted on-line using a Waters Symmetry C18 trap column
(180 m by 20 mm, 5 m). The sample injection volume was typically 7.5 l, and LC was performed by
using a BEH 130 C18 column (100 m by 100 mm, 1.7 m) and eluting with a 0.5-l/min flow with a linear
gradient (10 to 40%) of acetonitrile containing 0.1% formic acid. Electrospray tandem mass spectra were
recorded using a quadrupole/orthogonal acceleration time of flight (Q-Tof) spectrometer (Waters)
interfaced to the nanoAcquity system capillary chromatograph. The electrospray ionization voltage was
set at 3,500 V, the source temperature was 80°C, and the cone voltage was 30 V. Instrument control and
data acquisition were conducted by a MassLynx data system (version 4.1; Waters), and experiments were
performed by scanning at a mass-to-charge ratio (m/z) of from 400 to 2,000 using a scan time of 1 s,
applied during the whole chromatographic process. The mass spectra corresponding to each signal from
the total ion current (TIC) chromatogram were averaged, allowing for accurate molecular mass mea-
surement. The exact mass was determined automatically using the LockSpray reference ion of the Q-Tof
spectrometer (Waters). Data-dependent MS/MS acquisitions were performed on precursors with charge
states of 2, 3, or 4 over a range of from 50 to 2,000 m/z and under a 2-m/z window. A maximum of three
ions were selected for MS/MS from a single MS survey. Collision-induced dissociation (CID) MS/MS
spectra were obtained using argon as the collision gas at a pressure of 40 lb/in2, and the collision voltage
was varied between 18 and 90 V, depending on the mass and charge of the precursor. All data were
processed using a ProteinLynx Global server (version 2.5; Waters). The processing corrected automatically
the m/z scale of both the MS and MS/MS data utilizing the LockSpray reference ion. Proteins were
identified by correlation of tandem mass spectra and the NCBInr database of proteins (which contains
3,782,683 sequences in the virus database; last update, 16 November 2016) using MASCOT software
(version 2.3; Matrix Science). One missed cleavage per peptide was allowed, and an initial mass tolerance
of 0.1 Da was used in all searches. Cysteines were assumed to be carbamidomethylated, and variable
modifications of methionine (oxidation) were allowed. An identification was considered positive if it
matched at least two peptides with a mass accuracy of better than 0.1 Da.
Partition coefficient determination. Studies on porphyrin partition to membranes were performed
in a Varian Cary Eclipse fluorescence spectrometer. The assay is based on the fact that the PPIX, ZnPPIX,
and MPIX fluorescence emission spectra are modified by changes in medium polarity, allowing the
porphyrin-membrane interaction to be quantified. The excitation wavelengths used were 394, 407, and
394 nm for PPIX, ZnPPIX, and MPIX, respectively, with the emission spectra being recorded from 550 to
700 nm. The bandwidths used were 10 nm for excitation and 5 nm for emission. Each emission spectrum
was corrected for dilution and for simultaneous light absorbance by porphyrin. The experiments
consisted of the successive addition of LUVs (POPC-POPE at a molar ratio of 4:1, POPC-POPS at 4:1,
POPC-Chol at 2:1, POPC-Sph at 2:1, or PC-Sph-Chol at 1:1:1) to the porphyrins diluted in PBS to a
concentration of 2.8 M for ZnPPIX and PPIX and 2.6 M for MPIX, with a 10-min incubation time being
used between each addition. Calculation of the partition coefficients (Kps) was performed as described
by Santos et al. (54). The experimental data were fit using equation 1:
I
I0

1 Kp · L ·
IL
I0
· L
1 Kp · L · L
(1)
where Kp is the partition coefficient; I, IL, and I0 are the fluorescence intensities (spectral area between 550
and 700 nm) in the presence of LUVs, in lipid environment, and in the absence of LUVs, respectively; L
is the lipid molar volume (we used an approximation for this value on the basis of the POPC lipid molar
ratio); and [L] is the lipid concentration. All measurements were done at 28°C.
GP. Alteration of membrane ordering due to the porphyrin interaction was evaluated by determi-
nation of the laurdan fluorescence spectral shift, as laurdan is sensitive to polarity changes in the
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medium. Viral samples at a protein concentration of 100 g/ml were incubated with 20 M laurdan in
PBS, pH 7.4, for 20 min at 4°C. After successive porphyrin addition (with a 10-min incubation time
between each addition), samples were excited at 360 nm and the fluorescence emission spectra were
recorded from 400 to 600 nm using a Spectroflourimeter PC1 (ISS Inc., Champaign, IL). Laurdan
generalized polarization (GP), which represents the shift in the laurdan spectrum induced by medium
polarity changes, was calculated as described in equation 2, adapted from the work of Parasassi et al. (55):
GP
I440 I490
I440 I490
(2)
where I440 and I490 are the emission intensities at 440 and 490 nm, respectively. All measurements were
done at 28°C.
1O2 production by porphyrins. 1O2 production was measured by determining DMA/oxi-DMA by
NMR spectroscopy. The porphyrin solution (0.001 M PPIX, 0.1 M ZnPPIX, or 0.01 M MPIX) was
incubated with 20 M DMA in NMR tubes, and the tubes were exposed or not exposed to visible light
(provided by a 30-W light lamp with a luminous emittance of 2,000 lx at a distance of 10 cm) for 5, 15,
30, or 60 min. The conversion of DMA (DMA methyl peak at 3.1 ppm) to oxi-DMA (oxi-DMA methyl peak
at 2.1 ppm) was measured by 1H NMR. All the spectra were recorded in a 500-MHz Bruker Avance
spectrometer at 298 K in deuterated CDCl3. The percentages of conversion were calculated by consid-
ering the integrals of the methyl peaks in two independent measurements.
Statistical analyses. Statistical analyses were performed using GraphPad Prism (version 6.0) soft-
ware. Group differences were compared using Student’s t test.
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